PNC Financial Services Group
NGNE icon

PNC Financial Services Group’s Neurogene NGNE Stock Holding History

PNC Financial Services Group’s Portfolio NGNE Stock Details NGNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$102K Sell
5,047
-77
-2% -$1.49K ﹤0.01% 2805
2025
Q4 		$106K Buy
5,124
+69
+1% +$1.72K ﹤0.01% 2769
2025
Q3 		$87.6K Buy
5,055
+1,000
+25% +$20.1K ﹤0.01% 2896
2025
Q2 		$60.6K Buy
4,055
+1,232
+44% +$19.3K ﹤0.01% 3006
2025
Q1 		$33.1K Sell
2,823
-303
-10% -$5.26K ﹤0.01% 3311
2024
Q4 		$71.5K Buy
+3,126
New +$116K ﹤0.01% 2895

Other funds holding NGNE

SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $437M AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

PNC Financial Services Group's NGNE Position: Q1 2026 in Review

PNC Financial Services Group reduced its Neurogene (NGNE) stake by 1.5% in Q1 2026, selling an estimated $1.49K and leaving 5,047 shares worth $102K. The position accounts for ﹤0.01% of the portfolio, ranked #2805.

PNC Financial Services Group first reported a position in NGNE in Q4 2024 and has held it in 6 quarters since. The position peaked at $106K in Q4 2025. 96 funds tracked by Wall St. Rank hold NGNE as of Q1 2026.

  • PNC Financial Services Group held 5,047 shares of Neurogene worth $102K as of Q1 2026.
  • PNC Financial Services Group sold 77 Neurogene shares in Q1 2026, an estimated $1.49K.
  • Neurogene made up ﹤0.01% of PNC Financial Services Group's portfolio in Q1 2026, its #2805 holding.
  • PNC Financial Services Group first reported a position in Neurogene in Q4 2024 and has held it in 6 quarters since.
  • PNC Financial Services Group's Neurogene position peaked at $106K in Q4 2025.
  • 96 funds tracked by Wall St. Rank held Neurogene as of Q1 2026.

Based on PNC Financial Services Group's 13F filing for Q1 2026, filed 8 May 2026.